Search results
McKesson misses quarterly estimates as US pharmaceuticals segment weighs
WSAU Wausau· 1 hour ago(Reuters) - McKesson Corp reported weaker-than-expected quarterly revenue and profit on Tuesday due to slump in demand for the company's branded and specialty drugs that dragged ...
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Zacks via Yahoo Finance· 1 day agoThe earnings season for the drug/biotech sector is now in its final lap, with two S&P 500 companies,...
Cencora beats profit estimates on strong demand for costly specialty drugs
Reuters via AOL· 7 days agoThe drug distributor has been benefiting from specialty drugs and biosimilars - close copies of complex biotech drugs - at a time when intense competition pulls down prices ...
Drugmaker Amneal agrees to $270 million U.S. opioid settlement
Reuters· 4 days ago, opens new tab said on Friday it had reached a deal valued at more than $270 million to resolve...
New York wins a share of $270M settlement against opioid manufacturer
Crain's New York Business· 4 days agoThe Bridgewater, New Jersey-based drug company was the largest manufacturer of generic opioids between 2006 and 2019, selling nearly ...
William Blair Commentary- Large-Cap Growth: Managing Risk and Seeking Consistent Returns
GuruFocus.com via Yahoo Finance· 9 hours agoWhile large-cap companies in the biopharmaceutical industry may benefit from sizable revenue streams...
California settles opioid complaint with company that sells overdose meds
Arizona Daily Sun· 1 day agoIf the name “Amneal Pharmaceuticals” rings a bell, it’s because just days earlier Gov. Gavin Newsom...
Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
Zacks via Yahoo Finance· 14 hours agoGiven the dynamic and evolving nature of technology, the sector is perceived to be riskier than the ...
Generic Drugmaker Amneal Announces Over $270M In US Opioid Lawsuit Settlement - Amneal...
Benzinga· 4 days agoThis move positions Amneal as the latest pharmaceutical company to resolve lawsuits brought forth by...
Amneal Pharmaceuticals wants to settle nationwide opioid cases for $272.5 million
Courthouse News Service· 4 days agoThe settlement, which doesn't include an admission of wrongdoing, would be payable over 10 years,...